NEMANA: Echocardiographic Standards and Sub-Saharian Africans (SSA) Migrants' in New Aquitaine Region

Sponsor
University Hospital, Limoges (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04865068
Collaborator
University Hospital, Bordeaux (Other)
100
1
1
15.5
6.5

Study Details

Study Description

Brief Summary

Standards Echocardiographic have been defined mainly on caucasian or Asian populations. In the EchoNoRMAL study the criteria for African populations were based solely on data from 198 subjects. This study suggests the presence of different standards depending on the ethnic origin of the subjects. The aims of this study is to describe the proportion of subjects reclassified (normal-pathological) according to the use of echocardiographic norm differences showed in TAHES population (Sub Saharian Africans) with those routinely used

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Echocardiography measures on SSA participants
N/A

Detailed Description

Sub-Saharian Africans populations seem to be more vulnerable in the field of health in general and in cardiovascular pathologies in particular.

  • The echocardiographic standards were mainly defined for Caucasian or Asian populations (EchoNoRMAL col. 2014 and 2015). In the EchoNoRMAL study, the criteria for the African populations were based on a reduced workforce (data from 198 subjects).

  • This study suggests the presence of different standards depending on the ethnic origin of the subjects. The authors noted that the establishment of references according to the ethnic origin of the subjects is necessary and highlighted the need for additional study for the underrepresented groups, in particular those including subjects of African origin.

The need for different ECG standards in African subjects, was confirmed in a study in the general African population (TAHES), represents 16% of immigrants in 2015 (INSEE According to reports from the health insurance funds, the migrant population,

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Echocardiographic Standards and Sub-Saharian Africans (SSA) Migrants' in New Aquitaine Region: NEMANA
Anticipated Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Sep 15, 2022
Anticipated Study Completion Date :
Sep 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: African migrant's population located in la region New Aquitaine.

Echocardiography norms will be harvested data on SSA participants located in la region New Aquitaine, France

Diagnostic Test: Echocardiography measures on SSA participants
Upon SSA Subject is admitted to the hospital for an echocardiography, Information about this study process, Participants will receive an information note ; Administration of a medical history questionnaire, collection of cardiovascular risk factors, weight toe (all of which are routinely collected before an echocardiographic examination is performed); Performing and recording the echocardiographic examination according to routine protocol delivery of the results according to the usual management; deferred analysis of the recordings on workstation with classification of the data (normal-pathological) according to the different standards

Outcome Measures

Primary Outcome Measures

  1. Proportion of subjects reclassified (from pathological to normal) according to the echocardiographic standard used (reference standard vs. TAHES standard). [18 months]

    Compare the echocardiography standards previously established in TAHES study to those used routinely managed for the population of SSA migrants in la region New Aquitaine, in order to define pathological subjects

Secondary Outcome Measures

  1. Describe the reasons of reclassification, based on the change of echocardiography standards use for the following criteria: left ventricular hypertrophy, left atrial dilatation, aortic dilatation, ascending, right ventricular dilatation [18 months]

    Identification and analyse the number of subjects requalified from pathological to normal) and identify reasons of the reclassifications after the use of the standards

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • SSA Major Subjects (first generation or from or from first generation parents) admitted to the hospital for an echocardiography
Exclusion Criteria:
  • Participation refusal;

  • Any acute heart disease (endocarditis, myocarditis, coronary syndrome);

  • Valvulopathy justifying an intervention;

  • Diseases of overload.

  • Any acute heart disease (endocarditis, myocarditis, coronary syndrome);

  • Valvulopathy justifying an intervention;

  • Diseases of overload.

  • Both participant and accompanying person unable to understand the information note written in French and in English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Explorations fonctionnelles vasculaires et angiologie (Hôpital Dupuytren) Limoges France 87000

Sponsors and Collaborators

  • University Hospital, Limoges
  • University Hospital, Bordeaux

Investigators

  • Principal Investigator: Philippe Lacroix, Professor, 0033555056391

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT04865068
Other Study ID Numbers:
  • 87RI20_0020 /NEMANA
First Posted:
Apr 29, 2021
Last Update Posted:
Apr 29, 2021
Last Verified:
Apr 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Limoges
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 29, 2021